Metformin Added to Insulin Not Beneficial for T2D in Pregnancy
TUESDAY, Dec. 12, 2023 -- For pregnant women with type 2 diabetes, the addition of metformin to insulin does not affect composite adverse neonatal outcomes, according to a study published in the Dec. 12 issue of the Journal of the American Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 12, 2023 Category: Pharmaceuticals Source Type: news
Metformin for Diabetes in Pregnancy: Maybe Not, Trial Says
(MedPage Today) -- Adding metformin to insulin treatment for pregnant women with preexisting type 2 or gestational diabetes did not reduce composite neonatal adverse outcomes, according to the randomized MOMPOD trial.
The composite outcome -... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 12, 2023 Category: Urology & Nephrology Source Type: news
Weight loss from Lilly's Zepbound reversed after stopping treatment, study shows
[1/2] Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023 after Eli Lilly and Co on Wednesday said it will cut list prices by 70% for its most commonly prescribed insulin products, Humalog and Humulin, beginning from the fourth quarter of this year. REUTERS/Mike…#sandiego #elililly #humulin #mikeblakefile #jama #lilly #zepbound #novonordisk #cowegovyandozempic #glp1 (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2023 Category: Consumer Health News Source Type: news
Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2D
MONDAY, Dec. 11, 2023 -- For drug-naive patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1RAs) are associated with a reduced risk for colorectal cancer (CRC) compared with other antidiabetics, including insulin... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 11, 2023 Category: Pharmaceuticals Source Type: news
What Happens When People Stop Taking the Weight Loss Drug Zepbound
As a new generation of highly effective weight loss drugs hits the market, doctors are still trying to figure out how long people will need to take them for the best results.
A new study offers a clue. Writing in JAMA, researchers report on what happens when people stop taking the weight loss drug tirzepatide, known as Zepbound. Tirzepatide can help people lose double digit percentages of their body weight, compared to single digit percentages with diet and exercise.
[time-brightcove not-tgx=”true”]
The study, sponsored by the drug’s manufacturer, Eli Lilly, included 670 people with a body mass in...
Source: TIME: Health - December 11, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Don't get burned: Expert tips and tricks on MRI safety
How can MRI staff reduce the impact of radiofrequency-induced heating? Are tattoos and implantable medical devices safe? How can quenching be avoided? What are the special risks in 7-tesla MRI? A prize-winning RSNA 2023 exhibit addressed these and other questions.
"While we are familiar with medical safety and ethics principles when errors occur, the culture of blaming parties is still prevalent," noted Ana Paula Santos Lima, MD, assistant professor of radiology at the University of Washington, and colleagues. "Everyone makes mistakes; it's crucial to minimize risks. It's not always direct staff at fault."
System-wide vu...
Source: AuntMinnie.com Headlines - December 11, 2023 Category: Radiology Authors: Philip Ward Tags: MRI Source Type: news
Two Automated Insulin Delivery Systems Upgrade Two Automated Insulin Delivery Systems Upgrade
Tandem Diabetes Care ' s t:slim X2 and Beta Bionics ' iLet will incorporate Dexcom G7, its latest continuous glucose monitoring system.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 8, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Dr Eric Berg has five simple ways for you to stop diabetes from developing
The doctor explained that to stop prediabetes from turning into diabetes, you need to tackle insulin resistance. (Source: Daily Express - Health)
Source: Daily Express - Health - December 8, 2023 Category: Consumer Health News Source Type: news
Mother-of-two trying to inject 'skinny jab' Ozempic into her body almost died when it turned out to be pure insulin and left her in a coma
When Michelle Sword emerged from her near-death experience she recalls doctors asking a series of probing questions as she lay in her hospital bed. (Source: the Mail online | Health)
Source: the Mail online | Health - December 8, 2023 Category: Consumer Health News Source Type: news
Medtronic cancels $738M acquisition of insulin-patch maker EOFlow
The deal for EOFlow, a Korean company that makes a wearable insulin patch, had been Medtronic's biggest M&A deal this year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 7, 2023 Category: Pharmaceuticals Source Type: news
Hope for hundreds of thousands with type 1 diabetes as major study reveals arthritis drug can suppress the condition
In a world-first clinical trial, researchers in Australia found that baricitinib can preserve the body's own insulin production. (Source: the Mail online | Health)
Source: the Mail online | Health - December 6, 2023 Category: Consumer Health News Source Type: news
Vegan Diet Confers Cardiometabolic Benefits Vegan Diet Confers Cardiometabolic Benefits
A healthy plant-based diet provided a significant reduction in LDL, as well as reductions in fasting insulin and weight compared with a healthy omnivore diet, in an 8-week controlled twin trial.Medscape Medical News (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - December 6, 2023 Category: Respiratory Medicine Tags: Cardiology Source Type: news
Are Immune Therapies for Type 1 Diabetes Worthwhile? Are Immune Therapies for Type 1 Diabetes Worthwhile?
Recently published studies of two different immunologic agents show beta-cell preservation in people with newly diagnosed disease, but no differences in glycemic control and ongoing insulin requirement.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 6, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes
Carmot Therapeutics ’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases both as standalone medicines and in combination with Roche ’s in-house assetsLead asset CT-388 is a Phase-2 ready dual GLP-1/GIP agonist with best-in-class potential for the treatment of obesity and its comorbiditiesUnder the terms of the agreement, Roche will pay a purchase price of USD 2.7 billion upfront and additional milestone payments of up to USD 400 millionBasel, 4 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive merger a...
Source: Roche Investor Update - December 4, 2023 Category: Pharmaceuticals Source Type: news
Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes
Carmot Therapeutics ’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases both as standalone medicines and in combination with Roche ’s in-house assetsLead asset CT-388 is a Phase-2 ready dual GLP-1/GIP agonist with best-in-class potential for the treatment of obesity and its comorbiditiesUnder the terms of the agreement, Roche will pay a purchase price of USD 2.7 billion upfront and additional milestone payments of up to USD 400 millionBasel, 4 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive merger a...
Source: Roche Media News - December 4, 2023 Category: Pharmaceuticals Source Type: news
